Hi Agent
Your thoughts about a possible aquisition align with my thinking based on one of the comments Jon Pilcher made at the Jefferies Health Conference. He was talking about NNZ2591 US rights, and the possibility of Neuren keeping the US rights (timestamp 18:00) He mentions that Neruen would have to step up their infrastruction if they want to do that. To me the obvious and quickest way to do that is the aquisition of US pharma who has those assets, realtionships, and capabilities in place. (like Acadia, but not necessarily Acadia). I could also be a backdoor way to list Neuren in the US.
Cheer
Muz
Share Price, page-5449
-
- There are more pages in this discussion • 5,507 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |